Literature DB >> 32522628

LncRNA double homeobox A pseudogene 8 (DUXAP8) facilitates the progression of neuroblastoma and activates Wnt/β-catenin pathway via microRNA-29/nucleolar protein 4 like (NOL4L) axis.

Lei Nie1, Chunyu Li1, Tana Zhao1, Ying Wang2, Jiewei Liu1.   

Abstract

The potential mechanism of neuroblastoma (NB) progression remains elusive. We intended to uncover the role and network of long noncoding RNA (lncRNA) double homeobox A pseudogene 8 (DUXAP8) in NB. Quantitative real time polymerase chain reaction (qRT-PCR) was performed to detect the levels of DUXAP8, microRNA-29 (miR-29) and nucleolar protein 4 like (NOL4L). The proliferation, colony formation, cell cycle and metastasis of NB cells were examined by (4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, plate colony formation assay, flow cytometry and transwell assays. Western blot was conducted to detect the expression of metastasis and proliferation-associated proteins and NOL4L. The target relationship was predicted by StarBase software and was confirmed by dual-luciferase reporter assay and RNA binding protein immunoprecipitation (RIP) assay. Nude mice bearing tumors were used to verify the role of DUXAP8 in vivo. We found the expression of DUXAP8 was positively related to the stage of NB tumors, and it was negatively associated with the survival rate of NB patients. DUXAP8 knockdown inhibited the proliferation, colony formation, cycle and motility of NB cells. MiR-29 could interact with DUXAP8, and DUXAP8 exacerbated NB via sponging miR-29. MiR-29 could bind to NOL4L, and the influence of NOL4L intervention on the functions of NB cells could be alleviated by the transfection of miR-29 inhibitor. NOL4L was regulated by DUXAP8/miR-29 axis in NB cells. DUXAP8 knockdown blocked the progression of NB in vivo. Collectively, DUXAP8 deteriorated NB through serving as a sponge for miR-29 to up-regulate the expression of NOL4L in vitro and in vivo.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DUXAP8; NOL4L; Neuroblastoma; Wnt/β-catenin pathway; miR-29

Year:  2020        PMID: 32522628     DOI: 10.1016/j.brainres.2020.146947

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Functions of lncRNA DUXAP8 in non-small cell lung cancer.

Authors:  Cui Wu; Wu Song; Zhongnan Wang; Bingmei Wang
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.316

2.  Demystifying the long noncoding RNA landscape of small EVs derived from human mesenchymal stromal cells.

Authors:  Chien-Wei Lee; Yi-Fan Chen; Allen Wei-Ting Hsiao; Amanda Yu-Fan Wang; Oscar Yuan-Jie Shen; Belle Yu-Hsuan Wang; Lok Wai Cola Ho; Wei-Ting Lin; Chung Hang Jonathan Choi; Oscar Kuang-Sheng Lee
Journal:  J Adv Res       Date:  2021-11-19       Impact factor: 12.822

Review 3.  LncRNAs and CircRNAs in cancer.

Authors:  Xin Yin; Huiran Lin; Lei Lin; Lei Miao; Jing He; Zhenjian Zhuo
Journal:  MedComm (2020)       Date:  2022-05-12

Review 4.  Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma.

Authors:  Omidvar Rezaei; Kasra Honarmand Tamizkar; Mohammadreza Hajiesmaeili; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

5.  LncRNA-DUXAP8 Regulation of the Wnt/β-Catenin Signaling Pathway to Inhibit Glycolysis and Induced Apoptosis in Acute Myeloid Leukemia

Authors:  Hong Zhai; Junting Zhao; Juan Pu; Pan Zhao; Jin Wei
Journal:  Turk J Haematol       Date:  2021-08-25       Impact factor: 1.831

6.  Targeting the lncRNA DUXAP8/miR-29a/PIK3CA Network Restores Doxorubicin Chemosensitivity via PI3K-AKT-mTOR Signaling and Synergizes With Inotuzumab Ozogamicin in Chemotherapy-Resistant B-Cell Acute Lymphoblastic Leukemia.

Authors:  Li Zhang; Shixia Zhou; Tiejun Zhou; Xiaoming Li; Junling Tang
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

7.  LncRNA DUXAP8 as a prognostic biomarker for various cancers: A meta-analysis and bioinformatics analysis.

Authors:  Yongfeng Wang; Xianglai Jiang; Dongzhi Zhang; Yuanbin Zhao; Xiaoyong Han; Lihui Zhu; Jingyao Ren; Yubin Liu; Jiarong You; Haolan Wang; Hui Cai
Journal:  Front Genet       Date:  2022-08-15       Impact factor: 4.772

Review 8.  The World of Pseudogenes: New Diagnostic and Therapeutic Targets in Cancers or Still Mystery Molecules?

Authors:  Maciej Stasiak; Tomasz Kolenda; Joanna Kozłowska-Masłoń; Joanna Sobocińska; Paulina Poter; Kacper Guglas; Anna Paszkowska; Renata Bliźniak; Anna Teresiak; Urszula Kazimierczak; Katarzyna Lamperska
Journal:  Life (Basel)       Date:  2021-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.